이상반응 보고

VAERS ID	1626887
성별	여성
나이	78세
주 코드	OH
제약회사	MODERNA
로트 번호	033C21A
예방접종 횟수	2
접종일	2021-06-09
발병일	2021-06-09
상태	회복

증상

• 백신 제품의 교환(Interchange of vaccine products)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

First Dose Pfizer, Second Dose Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (First Dose Pfizer, Second Dose Moderna) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no.
033C21A) for COVID-19 vaccination.
Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.
No Medical History information was reported.
On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.
On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form.
On 09-Jun-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (First Dose Pfizer, Second Dose Moderna).
On 09-Jun-2021, INTERCHANGE OF VACCINE PRODUCTS (First Dose Pfizer, Second Dose Moderna) had resolved.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No concomitant medication information was reported.
No treatment medication information was reported.
Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: The follow up received is non significant no new information was updated